1-2 of 2
Bruno Salles, MD
Close
Sort by
Journal Articles

Use of Clofarabine in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia in Adults: The French Experience

David Sibon, MD, PhD, Ana Berceanu, MD, David Ghez, MD, PhD, Frantz Foissac, Leila Kammoun, MD, Thorsten Braun, MD, Denis Caillot, MD, Mario Ojeda-Uribe, MD, Romain Guieze, MD, Céline Berthon, MD, Laurence Sanhes, MD, Bérengère Gruson, MD, Didier Bouscary, MD, PhD, Christian Recher, MD, PhD, Laure Stalnikiewicz, MD, Philippe Rousselot, MD, PhD, Emmanuel Raffoux, MD, PhD, Thomas Prebet, MD, PhD, Bruno Salles, MD, Stéphane de Botton, MD, PhD, Ambroise Marcais, MD, Felipe Suarez, MD, PhD, Olivier Hermine, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 2623.
https://doi.org/10.1182/blood.V118.21.2623.2623
Published: 2011
Journal Articles

Rituximab and Reduced Dose CHOP (R-mini-CHOP) for Patients Over 80 Years with Diffuse Large B-Cell Lymphoma (DLBCL) – Groupe d'Etude Des Lymphomes De l'Adulte (GELA) Study LNH03-7B

Frederic Peyrade, Fabrice Jardin, MD, PhD, Christian Gisselbrecht, Antoine Thyss, Jean François Emile, MD, Sylvie Castaigne, MD, Bertrand Coiffier, MD, PhD, Corinne Haioun, MD, Serge Bologna, Olivier Fitoussi, Gerard Lepeu, MD, Christophe Fruchart, Dominique Bordessoule, PhD, Michel Blanc, MD, Richard Delarue, Maud Janvier, MD, Bruno Salles, MD, Andre Bosly, MD, Herve Tilly
Journal: Blood
Blood (2010) 116 (21): 853.
https://doi.org/10.1182/blood.V116.21.853.853
Published: 2010